Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply.
Ines Pires da Silva,Tasnia Ahmed,Irene L M Reijers,Allison Betof Warner,James Randall Patrinely,Patricio Serra-Bellver,Clara Allayous,Joanna Mangana,Lisa Zimmer,Claudia Trojaniello,Oliver Klein,Camille L Gerard,Olivier Michielin,Andrew Haydon,Paolo A Ascierto,Matteo S Carlino,Celeste Lebbe,Paul Lorigan,Douglas B Johnson,Shahneen Sandhu,Serigne N Lo,Alexander M Menzies,Georgina V Long The Lancet. Oncology(2021)
AI 理解论文
溯源树
样例